So far, 2025 has brought significant excitement and progress to the complement-based therapeutic landscape. Leading biopharma companies like Novartis, Annexon Biosciences and Omeros, are making significant clinical progress in PNH, AMD, IgAN and C3G, whilst key academics such as Michael Holers, Michael Brenner, and Brahm Segal continue to make discoveries in complement imaging, novel pathways, and new therapeutics areas such as oncology and transplantation.

Date and Time: Monday, 01 December 2025 at 08:00 to Wednesday, 03 December 2025 at 16:40

Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States

Prices:
USD 2599.00 – USD 5097.00